Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept for diabetic macular edema long‑term extension (SAILING extension)
CTR20201776Phase 3Completed
- Sponsor
- Chengdu Kanghong Biotechnology Co., Ltd.
- Start
- Sep 2020
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of conbercept in diabetic macular edema (DME), sponsored by Chengdu Kanghong Biotechnology Co., Ltd.. Started Sep 2020; status: completed.
02
Drugs
conbercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on CTR20201776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201776.